vs
普立万（AVNT）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是普立万的1.9倍（$1.4B vs $760.6M），瑞思迈净利率更高（27.6% vs 2.2%，领先25.4%），瑞思迈同比增速更快（11.0% vs 1.9%），瑞思迈自由现金流更多（$311.2M vs $125.4M），过去两年瑞思迈的营收复合增速更高（9.0% vs -4.2%）
普立万公司是一家全球性材料解决方案供应商，总部位于美国俄亥俄州埃文湖，全球员工约9000人。主营产品涵盖色母粒、先进复合材料、功能添加剂以及工程材料，为多行业客户提供定制化的材料相关技术支持与解决方案。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
AVNT vs RMD — 直观对比
营收规模更大
RMD
是对方的1.9倍
$760.6M
营收增速更快
RMD
高出9.1%
1.9%
净利率更高
RMD
高出25.4%
2.2%
自由现金流更多
RMD
多$185.8M
$125.4M
两年增速更快
RMD
近两年复合增速
-4.2%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $760.6M | $1.4B |
| 净利润 | $16.9M | $392.6M |
| 毛利率 | 30.2% | 61.8% |
| 营业利润率 | 5.2% | 34.6% |
| 净利率 | 2.2% | 27.6% |
| 营收同比 | 1.9% | 11.0% |
| 净利润同比 | -65.0% | 13.9% |
| 每股收益（稀释后） | $0.18 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVNTRMD
| Q4 25 | $760.6M | $1.4B | ||
| Q3 25 | $806.5M | $1.3B | ||
| Q2 25 | $866.5M | $1.3B | ||
| Q1 25 | $826.6M | $1.3B | ||
| Q4 24 | $746.5M | $1.3B | ||
| Q3 24 | $815.2M | $1.2B | ||
| Q2 24 | $849.7M | $1.2B | ||
| Q1 24 | $829.0M | $1.2B |
净利润AVNTRMD
| Q4 25 | $16.9M | $392.6M | ||
| Q3 25 | $32.6M | $348.5M | ||
| Q2 25 | $52.6M | $379.7M | ||
| Q1 25 | $-20.2M | $365.0M | ||
| Q4 24 | $48.3M | $344.6M | ||
| Q3 24 | $38.2M | $311.4M | ||
| Q2 24 | $33.6M | $292.2M | ||
| Q1 24 | $49.4M | $300.5M |
毛利率AVNTRMD
| Q4 25 | 30.2% | 61.8% | ||
| Q3 25 | 30.4% | 61.5% | ||
| Q2 25 | 32.1% | 60.8% | ||
| Q1 25 | 31.8% | 59.3% | ||
| Q4 24 | 34.8% | 58.6% | ||
| Q3 24 | 32.1% | 58.6% | ||
| Q2 24 | 30.3% | 58.5% | ||
| Q1 24 | 33.6% | 57.9% |
营业利润率AVNTRMD
| Q4 25 | 5.2% | 34.6% | ||
| Q3 25 | 8.3% | 33.4% | ||
| Q2 25 | 11.1% | 33.7% | ||
| Q1 25 | 0.1% | 33.0% | ||
| Q4 24 | 11.5% | 32.5% | ||
| Q3 24 | 9.5% | 31.6% | ||
| Q2 24 | 8.5% | 31.2% | ||
| Q1 24 | 11.3% | 31.3% |
净利率AVNTRMD
| Q4 25 | 2.2% | 27.6% | ||
| Q3 25 | 4.0% | 26.1% | ||
| Q2 25 | 6.1% | 28.2% | ||
| Q1 25 | -2.4% | 28.3% | ||
| Q4 24 | 6.5% | 26.9% | ||
| Q3 24 | 4.7% | 25.4% | ||
| Q2 24 | 4.0% | 23.9% | ||
| Q1 24 | 6.0% | 25.1% |
每股收益（稀释后）AVNTRMD
| Q4 25 | $0.18 | $2.68 | ||
| Q3 25 | $0.36 | $2.37 | ||
| Q2 25 | $0.57 | $2.58 | ||
| Q1 25 | $-0.22 | $2.48 | ||
| Q4 24 | $0.53 | $2.34 | ||
| Q3 24 | $0.41 | $2.11 | ||
| Q2 24 | $0.36 | $1.97 | ||
| Q1 24 | $0.54 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $1.9B | $403.9M |
| 股东权益账面价值 | $2.4B | $6.3B |
| 总资产 | $6.0B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.81× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资AVNTRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务AVNTRMD
| Q4 25 | $1.9B | $403.9M | ||
| Q3 25 | $2.0B | $408.7M | ||
| Q2 25 | $2.0B | $658.4M | ||
| Q1 25 | $2.1B | $663.1M | ||
| Q4 24 | $2.1B | $662.9M | ||
| Q3 24 | $2.1B | $667.6M | ||
| Q2 24 | $2.1B | $697.3M | ||
| Q1 24 | $2.1B | $997.0M |
股东权益AVNTRMD
| Q4 25 | $2.4B | $6.3B | ||
| Q3 25 | $2.4B | $6.1B | ||
| Q2 25 | $2.4B | $6.0B | ||
| Q1 25 | $2.3B | $5.5B | ||
| Q4 24 | $2.3B | $5.3B | ||
| Q3 24 | $2.4B | $5.2B | ||
| Q2 24 | $2.3B | $4.9B | ||
| Q1 24 | $2.3B | $4.6B |
总资产AVNTRMD
| Q4 25 | $6.0B | $8.5B | ||
| Q3 25 | $6.1B | $8.3B | ||
| Q2 25 | $6.1B | $8.2B | ||
| Q1 25 | $5.8B | $7.6B | ||
| Q4 24 | $5.8B | $7.1B | ||
| Q3 24 | $6.0B | $7.2B | ||
| Q2 24 | $5.9B | $6.9B | ||
| Q1 24 | $5.9B | $6.8B |
负债/权益比AVNTRMD
| Q4 25 | 0.81× | 0.06× | ||
| Q3 25 | 0.83× | 0.07× | ||
| Q2 25 | 0.86× | 0.11× | ||
| Q1 25 | 0.90× | 0.12× | ||
| Q4 24 | 0.89× | 0.13× | ||
| Q3 24 | 0.88× | 0.13× | ||
| Q2 24 | 0.90× | 0.14× | ||
| Q1 24 | 0.90× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $167.8M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $125.4M | $311.2M |
| 自由现金流率自由现金流/营收 | 16.5% | 21.9% |
| 资本支出强度资本支出/营收 | 5.6% | 2.0% |
| 现金转化率经营现金流/净利润 | 9.93× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $195.0M | $1.8B |
8季度趋势，按日历期对齐
经营现金流AVNTRMD
| Q4 25 | $167.8M | $339.7M | ||
| Q3 25 | $72.1M | $457.3M | ||
| Q2 25 | $112.8M | $538.8M | ||
| Q1 25 | $-51.1M | $578.7M | ||
| Q4 24 | $122.6M | $308.6M | ||
| Q3 24 | $71.1M | $325.5M | ||
| Q2 24 | $105.9M | $440.1M | ||
| Q1 24 | $-42.8M | $402.0M |
自由现金流AVNTRMD
| Q4 25 | $125.4M | $311.2M | ||
| Q3 25 | $47.4M | $414.4M | ||
| Q2 25 | $85.8M | $508.2M | ||
| Q1 25 | $-63.6M | $557.9M | ||
| Q4 24 | $81.5M | $288.0M | ||
| Q3 24 | $46.1M | $307.7M | ||
| Q2 24 | $74.5M | $415.2M | ||
| Q1 24 | $-67.2M | $380.8M |
自由现金流率AVNTRMD
| Q4 25 | 16.5% | 21.9% | ||
| Q3 25 | 5.9% | 31.0% | ||
| Q2 25 | 9.9% | 37.7% | ||
| Q1 25 | -7.7% | 43.2% | ||
| Q4 24 | 10.9% | 22.5% | ||
| Q3 24 | 5.7% | 25.1% | ||
| Q2 24 | 8.8% | 33.9% | ||
| Q1 24 | -8.1% | 31.8% |
资本支出强度AVNTRMD
| Q4 25 | 5.6% | 2.0% | ||
| Q3 25 | 3.1% | 3.2% | ||
| Q2 25 | 3.1% | 2.3% | ||
| Q1 25 | 1.5% | 1.6% | ||
| Q4 24 | 5.5% | 1.6% | ||
| Q3 24 | 3.1% | 1.5% | ||
| Q2 24 | 3.7% | 2.0% | ||
| Q1 24 | 2.9% | 1.8% |
现金转化率AVNTRMD
| Q4 25 | 9.93× | 0.87× | ||
| Q3 25 | 2.21× | 1.31× | ||
| Q2 25 | 2.14× | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | 2.54× | 0.90× | ||
| Q3 24 | 1.86× | 1.05× | ||
| Q2 24 | 3.15× | 1.51× | ||
| Q1 24 | -0.87× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
